Ponatinib
Ponatinib is a multi-targeted tyrosine kinase inhibitor that is active against T315I and other BCR-Abl mutants. It inhibits all tested BCR-Abl mutants in cellular and biochemical assays, suppresses BCR-Abl(T315I)-driven tumor growth in mice, and completely abrogates resistance in cell-based mutagenesis screens.
Product Specifications
Shipping Conditions
Gel pack
Storage Conditions
-20°C
Shelf Life
36 months
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV629480 1.0 µg DNA
Olr1148 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA)
Sign In for Pricing
View Details CF-488A-20-5-20μglabeling 5-20 μg Labeling
Mix-n-Stain™ CF®488A Antibody Labeling Kit
Sign In for Pricing
View Details 
AP55823PU-N 100 µL
MAPKAP Kinase 2 (MAPKAPK2) pSer272 Rabbit Polyclonal Antibody
Sign In for Pricing
View Details